AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...

Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report ...

AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

The AstraZeneca PLC ADR AZN inched 0.47% higher to $64.79 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.06% to ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...

(Reuters) -AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...